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Abstract
Background: Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) is the etiological agent of adult T-cell leukemia (ATL) and
HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). It has been estimated that 10–20 million people are
infected worldwide, but no successful treatment is available. Recently, the epidemiology of this virus was addressed in
blood donors from Maputo, showing rates from 0.9 to 1.2%. However, the origin and impact of HTLV endemic in this
population is unknown.
Objective: To assess the HTLV-1 molecular epidemiology in Mozambique and to investigate their relationship with HTLV-1
lineages circulating worldwide.
Methods: Blood donors and HIV patients were screened for HTLV antibodies by using enzyme immunoassay, followed by
Western Blot. PCR and sequencing of HTLV-1 LTR region were applied and genetic HTLV-1 subtypes were assigned by the
neighbor-joining method. The mean genetic distance of Mozambican HTLV-1 lineages among the genetic clusters were
determined. Human mitochondrial (mt) DNA analysis was performed and individuals classified in mtDNA haplogroups.
Results: LTR HTLV-1 analysis demonstrated that all isolates belong to the Transcontinental subgroup of the Cosmopolitan
subtype. Mozambican HTLV-1 sequences had a high inter-strain genetic distance, reflecting in three major clusters. One
cluster is associated with the South Africa sequences, one is related with Middle East and India strains and the third is a
specific Mozambican cluster. Interestingly, 83.3% of HIV/HTLV-1 co-infection was observed in the Mozambican cluster. The
human mtDNA haplotypes revealed that all belong to the African macrohaplogroup L with frequencies representatives of
the country.
Conclusions: The Mozambican HTLV-1 genetic diversity detected in this study reveals that although the strains belong to
the most prevalent and worldwide distributed Transcontinental subgroup of the Cosmopolitan subtype, there is a high
HTLV diversity that could be correlated with at least 3 different HTLV-1 introductions in the country. The significant rate of
HTLV-1a/HIV-1C co-infection, particularly in the Mozambican cluster, has important implications for the controls programs
of both viruses.
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Introduction
Human T-cell lymphotropic virus type 1 was the first oncogenic
human retrovirus to be identified in 1980 [1] In 1982, the second
type, HTLV-2, was discovered [2]. These two human viruses
originated independently through zoonotic infections from lineages of
simian T-lymphotropic virus (STLV-1 and STLV-2). These inter-
speciestransmissioneventshavebeenoccurringinAfricauptorecent
times [3–4]. In 2005, Wolfe ND [5] and Calattini S [6], reported the
discovery of the third and fourth HTLV types (HTLV type 3 and 4)
in asymptomatic Cameroonese hunters. Some studies had revealed
Western blot profiles compatible with HTLV-1 and HTLV-2 in
those individuals suggesting an appreciable cross-reaction between
these viruses [5,7].
HTLV-1 has a remarkable genetic stability when compared
with other retroviruses such as HIV (Human Immunodeficiency
www.plosntds.org 1 April 2011 | Volume 5 | Issue 4 | e1038Virus). However, based on the nucleotide diversity of its LTR
region, HTLV-1 can be grouped in 6 major genetic subtypes (a–f),
most of them linked to some geographic regions [5,8–12] All
subtypes are present in Africa with different prevalences, except
for HTLV-1c that has, so far, only been identified in Melanesia
[13]. The genetic lineages of HTLV-1a subtype, also known as
Cosmopolitan group, are found all over the world. This group can
be further divided in distinct sub-groups, which are characteristics
of geographical localization of HTLV-1 infections. The HTLV-1a
Cosmopolitan subgroups identified as driving the HTLV infection
in Africa were HTLV-1aD or North African subgroup, which is
prevalent in Senegal, Guinea Bissau, Morocco, and the transcon-
tinental subgroup in South Africa [14]. HTLV-1 is the etiological
agent of Adult T-Cell Leukemia/Lymphoma (ATL) and Tropical
Spastic Paraparesis/HTLV-1-associated Myelopathy (TSP/
HAM). Efforts to disrupt its transmission have been taken in
some countries, including the screening of blood donors for the
presence of HTLV antibodies.
HTLV screenings performed in many African countries have
been limited to sero-epidemiological surveys studies using ELISA
and Western Blot criteria for HTLV typing [15–16]. Recently, the
epidemiology of this virus was addressed in donors attending the
blood bank of the Maputo city showing rates from 0.9 to 1.2%
[17–18]. Additionally, a study conducted in 1999 showed that four
TSP/HTLV patients from Mozambique were infected with
Cosmopolitan HTLV-1 subtype A [19]. It has recently been
shown that the prevalence of HTLV among HIV-infected patients
in Mozambique is 4.5%, much higher than in blood donors [20].
Mozambique is one of the countries in sub-Saharan Africa with
the highest HIV prevalence rates in adult population. The HIV
seroprevalence among pregnant women in Mozambique rise in
the proportion of infected women of 14.0% in 2002, 17.8% in
2003, 16.5% in 2004, and 20.2% in 2005 [21]. In another
serosurvey performed in 2007, a prevalence of HIV infection
around 18% was found in women attending antenatal services
[22]. HIV-1 subtype C is the major variant of the HIV/AIDS
epidemic in the country [23]. However, the status of HIV and
HTLV co-infections in Mozambique is still poorly documented, as
well as, the subtypes/subgroups of these viruses.
The aim of this study was to investigate the molecular identities
of HTLV in Mozambique and therefore to gain insights to HTLV
infection in the country, focusing on a set of HTLV seropositive




Both Co-infection Protocol (148/CNBS/05) as well the Blood
Bank Study (78/CNBS/06) were reviewed by National Center in
Bioethics in Health (CNBS) located in MOH, Maputo, Mozam-
bique. All subjects provided written informed consent and were
included in the study.
Samples
HTLV-1 positive samples were originated from a cross-sectional
study conducted among 2019 repeat blood donors at the Maputo
Central Hospital blood bank in Maputo city between August and
December 2006, where the prevalence of the infection is 0.9%
[18]. HTLV/HIV positive samples were originated from a cross-
sectional survey conducted among HIV-positive adult individuals
naive to Highly Active Antiretroviral Therapy (HAART) attend-
ing an HIV Outpatient Clinic in Maputo, between March and
June of 2006, with prevalence of HTLV/HIV co-infection of
4.5%. Demographic information is on Gudo et al. [18]. All
twenty-five specimens, 14 from blood donors and 11 from HTLV/
HIV co-infected individuals, were positive by HTLV enzyme
immunoassays [Murex HTLV I+II, (Abbott/Murex, Wiesbaden,
Germany) and Vironostika HTLVI/II (bioMe ´rieux bv, Boxtel,
Netherlands], and confirmed by HTLV BLOT 2.4 (Genelabs
Diagnostics, Singapura). The HIV positive individuals were
screened by two rapid tests: Determine HIV 1/2 test (Abbott
Laboratories, Tokyo, Japan) and Unigold HIV test (Trinity
Biotech, Ireland).
Genetic analysis
High molecular weight DNA was extracted from whole-blood
samples of all 25 subjects using QIAamp DNA Blood Mini kit
(Qiagen). The PCR for HTLV typing was carried out as described
[24]. The HTLV-1 subtyping was performed with amplification of
672 bp fragment from the LTR region under conditions published
previously [25] using Pfu DNA polymerase (Stratagene). Human
mitocondrial (mt) DNA hypervariable segment I (HVS-I) (302 bp)
was accessed by PCR using conditions formerly described [26].
The amplicons were separated on a 2% agarose gel and visualized
under UV light after ethidium bromide staining. PCR products
corresponding to HTLV-1 LTR and mtDNA HVS-I regions were
purified using QIAamp PCR purification kit (Qiagen) according to
the manufacturer’s instructions. The amplicons were directly
sequenced on both strands using the BigDye Terminator v3.1
Cycle Sequencing Kit, with a 3730 Automated DNA Sequencer
(Applied Biosystems, USA) and the bioinformatics pipeline
Chromapipe [27].
LTR sequences were editing and alignment using BioEdit
v5.0.9. (Department of Microbiology, North Carolina State
University, USA) and Clustal W programs, respectively. Neigh-
bor-joining (NJ) tree was build by PAUP* software version 4.0b10
[28]. The HKY model with gamma distribution was selected using
Author Summary
Human T-cell lymphotropic virus type 1 (HTLV-1) is the
causative agent of Adult T-Cell Leukemia/Lymphoma
(ATL), the Tropical Spastic Paraparesis/HTLV-1-associated
Myelopathy (TSP/HAM) and other inflammatory diseases,
including dermatitis, uveitis, and myositis. It is estimated
that 2–8% of the infected persons will develop a HTLV-1-
associated disease during their lifetimes, frequently TSP/
HAM. Thus far, there is not a specific treatment to this
progressive and chronic disease. HTLV-1 has means of
three transmission: (i) from mother to child during
prolonged breastfeeding, (ii) between sexual partners
and (iii) through blood transfusion. HTLV-1 has been
characterized in 7 subtypes and the geographical distri-
bution and the clinical impact of this infection is not well
known, mainly in African population. HTLV-1 is endemic in
sub-Saharan Africa. Mozambique is a country of south-
eastern Africa where TSP/HAM cases were reported.
Recently, our group estimated the HTLV prevalence
among Mozambican blood donors as 0.9%. In this work
we performed a genetic analysis of HTLV-1 in blood donors
and HIV/HTLV co-infected patients from Maputo, Mozam-
bique. Our results showed the presence of three HTLV-1
clusters within the Cosmopolitan/Transcontinental sub-
type/subgroup. The differential rates of HIV-1/HTLV-1 co-
infection in the three HTLV-1 clusters demonstrated the
dynamic of the two viruses and the need for implemen-
tation of control measures focusing on both retroviruses.
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bootstrap analysis of 1000 replicates. The mean genetic distance
among the Mozambican HTLV-1 clusters were determined using
nucleotide p-distance model and standard error estimated by a
bootstrap procedures (1000 replicates) on Mega4 software [30].
Mozambican HTLV-1 sequences are available at GeneBank
(accession number GU194504-GU194528).
The mtDNA sequences were classified in haplogroups in
agreement with the HSV-I nucleotide polymorphisms described
[26,31–32]. The HVS-I nucleotide sequences are available at
GeneBank (accession number FJ888491-FJ888504; HM775388-
HM775395).
Results
The results of screening for anti-HTLV-1+2 antibodies and
confirmed by a Western blot assay (HTLV BLOT 2.4, Genelabs
Diagnostics, Switzerland) are in Figure 1. Most of blood donors
with reactivity to antigens encoded by the gag and env genes were
considered as infected by HTLV, according to the instructions
provided by the manufacturer. Two samples were negative to p53
band and one to P19. All HTLV positive samples in our study
population were reactive to rgp46-HTLV-I and typed as solely
infected with HTLV-1 by Western blot with no reaction to
recombinant rgp46-HTLV-II.
The genetic analysis of 25 Mozambican LTR sequences, using
32 reference sequences representing all HTLV-1 subtypes and
sub-groups, as well as African HTLV-1 sequences, clearly
demonstrated that all isolates belong to the Transcontinental
subgroup of the Cosmopolitan subtype (Figure 2). These new
sequences from Mozambique showed an inter-strain genetic
distance ranging from 0.0 to 3.4% with an overall mean distance
of 1.6% and standard error (SE) estimated of 0.3. This variability
is reflected in the grouping of Mozambican LTR sequences in
three major clusters (Figure 2). Thirteen from 25 Mozambican
(MZ) sequences are close together with sequences from South
Africa (SA) forming a consistent branch, supported by a bootstrap
value of 71%. This cluster, named MZ/SA, has an inter-strain
genetic distance of 0.0–2.1% (01.1%; SE=0.2) and is character-
ized by the polymorphism C386T (ATK reference sequence). Four
sequences with inter-strain genetic distance ranging from 1.0–
2.1%, mean diversity of 1.4% (SE=0.3) are related with the
sequence HE (GenBank S76263) from Israel, which belongs to
Middle East cluster as showed by Ohkura and others, 1999.
Another genetic analysis including more HTLV-1 sequences from
this geographical region, based on 490 pb, showed that those 4
Mozambican sequences forming a monophyletic group with
sequences from Middle East (ME): KUW3, SAS, IRN4, Abl and
India: AP15, TNA (data not shown). The cluster named MZ/ME,
is supported by a bootstrap value of 76% and sequences are
characterized by a 6 nt deletion between 182–186 nt positions and
present the substitutions A240G and A575C. Of note, 6
Mozambican distinct sequences (16 MZ, 217 MZ, 526 MZ,
1180 MZ, 284 MZ, 541 MZ) with mean genetic distance of
0.8% (0.0–01.8%; SE=0.2) determined the MZ cluster with a
high bootstrap support of 89% and characterized by three
nucleotide changes: C365T, T573C, and C574T. Some of these
HTLV infected individuals (11/25=44.0%) were HIV-1 co-
infected (Figure 1). In fact, the HIV-1 subtype found in all HTLV
co-infected individuals, the HIV-1 subtype C, is the major HIV
subtype circulating in Maputo, as shown by Abreu et al., 2008
[23]. A slight correlation of HIV/HTLV co-infection with cluster
MZ could be observed (5/6=83.3%). MZ/ME and MZ/SA
clusters have HIV/HTLV co-infection frequencies of 25.0% and
45.4%, respectively (Figure 2).
In order to check the representativeness of this sampling in
relation to Mozambican population, mtDNA haplogroup analysis
was conducted. This analysis, based on HSV-I sequence motifs,
revealed that all those Mozambican individuals belong to African
macrohaplogroup L, including the sub-haplogroups L1a, L1c,
L1d, L2a, L3d and L3e. The African haplotypes were detected at
different frequencies of L1a (28%), L1c (8%), L1d (12%), L2a
(36%), L3d (12%), L3e (4%) and indistinctly distributed within the
3 HTLV-1 LTR clusters described above.
Discussion
The two pandemic human retroviruses, HIV and HTLV, were
originated as zoonoses in Africa at very distinct times. HTLV is an
ancient virus while HIV emerged in the early 20th century [33–
34]. The present study characterized the HTLV-1 strains in blood
donors and HTLV/HIV co-infected individuals from Maputo
city, Mozambique, as well as, determined the genetic background
of those individuals.
The HSV-I mtDNA haplogroup analysis from HTLV-1
infected individuals revealed that all the Mozambican sequences
belong to African sub-Saharan haplogroups. It was not possible to
establish a correlation between HTLV-1 lineages and a specific
ethnics group, since diverse mtDNA haplotypes were observed in
the three HTLV-1LTR clusters. All African sub-haplogroups
detected in this study (L1a, L1c, L1d, L2a, L3d and L3e) were
reported as the major frequencies in Mozambique [21;25]. In fact,
sub-haplogroups L2a and L1a were detected at the highest
frequencies (36% and 28%, respectively), as reported in previous
studies of Mozambican population. An mtDNA analysis of 109
unrelated individuals, corresponding to 30 ethnic groups, showed
the L2a and L1a sub-haplogroups with the highest frequencies of
47% and 16%, respectively [21]. A larger analysis, using 307
samples from 16 different population groups from Mozambique
Figure 1. WB patterns of Mozambican individuals infected by
HTLV-1. Lane 1: HTLV-1 positive control; lane: 2 HTLV-2 positive
control; lane 3–7: plasma samples; lane 8: HTLV-1/2 negative control.
doi:10.1371/journal.pntd.0001038.g001
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www.plosntds.org 3 April 2011 | Volume 5 | Issue 4 | e1038Figure 2. Genetic Analysis of Mozambican HTLV-1 LTR strains. HTLV-1 LTR (630 bp) genetic tree of 25 Mozambican isolates with HTLV-1
references and worldwide sequences were constructed using Neighbor Joining method based on HKY model and c-distribution. Bootstrap values
were calculated by the analysis of 1000 replicates. Only bootstraps values .50 are shown. HTLV strains from this study are in boxes and HIV-1 co-
infected samples have a black losange. HTLV-1a sub-clusters are in a circle.
doi:10.1371/journal.pntd.0001038.g002
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tion, with L1a and L2a (28% and 27%, respectively) as the major
sub-haplogroups, differently from other geographical regions in
Africa [35]. Haplogrup composition and their frequencies are
characteristic of main African regions. In South Africa, there is a
predominance of mtDNA haplogroup L1d/k, but L2a and L1a are
in low frequencies. Central and West Africa, also present high
frequencies of haplotypes [L1c and L2* (L2 other than L2a1),
respectively], which in Mozambique is less representative [35].
Therefore, we can conclude that the Mozambican HTLV-1 cohort
considered in our study is representative of the country population.
The sub-Saharan Africa is considered to be endemic for HTLV-
1 infection, with overall seroprevalence rates in Western and
Central African countries being similar to the ones observed in
Eastern and Southern African countries [17,18,36–38]. However,
there is lack of data concerning the HTLV molecular epidemi-
ology in Eastern African countries, contrasting with studies in
Western countries and South Africa [14,39]. In spite of HAM/
TSP cases have been reported in Africa [3], including Mozam-
bique [19], there is no information on the clinical impact of
HTLV-1 in African population. The risk of HTLV-I-associated
diseases among carriers differs substantially across geographic
areas and according to other population characteristics. ATL is
reported to be prevalent among individuals in Japan, while
Brazilian patients tend to present the HAM/TSP disease, and in
Jamaica these two HTLV-1 related illness are quite frequent,
suggesting that particular genetic backgrounds may play a role in
the disease development [40].
Most of the genetic variability of HTLV-1 is represented in
Africa, where the virus was originated [41]. Mozambique is located
on the southeast region of the continent, and the presence of
HTLV-1 has alsobeenreported incountries that share borders with
Mozambique [40]. The characterization of HTLV-1 Transconti-
nental subgroup as the prevalent subgroup driving the HTLV
epidemics in Mozambique, and South Africa [38] shows that there
are, at least, two major endemic lineages of Cosmopolitan HTLV-1
in Africa. One, dominating the Northwestern part of the continent,
driven by HTLV-1aD trans-Saharan lineage, as proposed by
Zehender [14] and a second lineage in Southern countries,
determined by Transcontinental HTLV-1 subgroup.
The genetic relationship of HTLV-1 Transcontinental sub-
group strains from South Africa and Mozambique suggests a
common origin of HTLV-1 in both countries, probably due to
their common peopling and migration patterns and their intense
commercial/migratory linkage and vicinity. It was interesting to
find a cluster joining Mozambique, Middle East and India strains
that can also be explained by a noticeable Indian population in
Maputo city due to the Indians people migration started in the
19
th century as well as, consequence of the migratory movements
between India and Austral Africa (1860) [42]. However, the
characterization of a cluster defined only by Mozambican strains
suggests the existence of HTLV-1 focus in the country. In fact, the
reproduction of Mozambican mtDNA haplogroup pattern on the
HTLV-1 cohort analyzed in this study, may explain the
particularities of HTLV-1 infection in the country. Mozambican
mtDNA haplogroup pattern have components from North and
South, with a high frequency of moderns haplogroups (L2),
haplogroups implicated in Bantu expansion (L1a and L3), but also
the ancient haplogroup L1d, characteristic of the extinct Khoisan-
speaking ethnic group [31,35], is present. Due to the diversity of
mtDNA haplogroup composite, we could speculate that both
ancient and recent introductions of HTLV-1 infection are
responsible for the current picture, modulates by breastfeeding
and sexual/injecting drug transmission ways, respectively. Of
concern, the significant rate of HTLV-1a/HIV-1subtype C co-
infection, particularly in the MZ cluster, demonstrates the
dynamic of the two viruses. In fact, the HIV-1/HTLV-1 co-
infection posses a great challenge in AIDS follow up tests such as
CD4 enumeration related to the prognosis [18], and the need for
implementation of public health control measures, as well clinical
protocols focusing on both HIV-1 and HTLV-1 in Mozambique.
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